Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

URLhttps://investors.amneal.com/news/press-releases/p
SourceAmneal
Date Published05/08/2025

Additional Reshoring Information:

Company/Division name Amneal Pharmaceuticals WITH Apiject Systems
Parent companyAmneal Pharmaceuticals WITH Apiject Systems
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):200
Year reshoring announced:2025
Year reshoring implemented or to be implemented:2026
City reshored to:Brookhaven
State(s) reshored to:NY
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredBFS-based injectable pharmaceuticals
What domestic positive factors made reshoring more attractive?Eco-system synergies
Find Reshoring Articles